Hyperglycemia, Risk of Subsequent Stroke, and Efficacy of Dual Antiplatelet Therapy: A Post Hoc Analysis of the POINT Trial
Autor: | Brian Mac Grory, Jonathan P. Piccini, Shadi Yaghi, Sven Poli, Adam De Havenon, Sara K. Rostanski, Martin Weiss, Ying Xian, S. Claiborne Johnston, Wuwei Feng |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2022 |
Předmět: | |
Zdroj: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 3 (2022) |
Druh dokumentu: | article |
ISSN: | 2047-9980 16606558 |
DOI: | 10.1161/JAHA.121.023223 |
Popis: | Background One‐quarter of all strokes are subsequent events. It is not known whether higher levels of blood glucose are associated with an increased risk of subsequent stroke after high‐risk transient ischemic attack or minor ischemic stroke. Methods and Results We performed a secondary analysis of the POINT (Platelet Oriented Inhibition in New TIA and Minor Ischemic Stroke) trial to evaluate the relationship between serum glucose hyperglycemia (≥180 mg/dL) versus normoglycemia ( |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |